MedTrace Logo

Developing a Smartphone App With Mindfulness Training for Teen Smoking Cessation

NCT02218281 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 146

Last updated 2016-08-26

No results posted yet for this study

Summary

The recent Surgeon General's Report calls for effective and readily available treatment approaches to help adolescent smokers interested in quitting. Schools are an ideal venue for connecting adolescent smokers with smoking cessation assistance. This study will adapt the Craving to Quit (C2Q) smartphone app, which integrates mindfulness training into a smoking cessation program, for teen smokers (C2Q-Teen). We will test how well this novel app helps teens stop smoking compared to another teen smoking cessation app that does not include mindfulness training, and to written cessation information alone. If effective, the C2Q-Teen would be relatively easy to disseminate widely and have tremendous public health significance

Conditions

  • Cigarette Smoking

Interventions

BEHAVIORAL

C2Q-Teen app

Commit to Quit (C2Q)-Teen app provides smoking cessation assistance incorporating mindfulness training.

BEHAVIORAL

NCI's QuitSTART app

NCI's smoking cessation app

BEHAVIORAL

Written smoking cessation materials only

Receipt of written smoking cessation materials

Sponsors & Collaborators

  • University of Massachusetts, Worcester

    lead OTHER

Principal Investigators

  • Lori Pbert, PhD · University of Massachusetts, Worcester

  • Judson Brewer, MD · University of Massachusetts, Worcester

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
13 Years
Max Age
19 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-09-30
Primary Completion
2016-06-30
Completion
2016-06-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02218281 on ClinicalTrials.gov